What is the current stock price of Datametrex AI Limited (DTMXF)?

As of the latest market data, Datametrex AI Limited (DTMXF) is trading at $0.04. The stock has seen a loss of 0.00% today.

Does Datametrex AI Limited (DTMXF) pay a dividend?

Based on current data, Datametrex AI Limited does not have a confirmed active dividend policy.

What is the market cap of Datametrex AI Limited?

The current market capitalization of Datametrex AI Limited (DTMXF) is approximately unavailable.

DTMXF

Datametrex AI Limited·Technology

0.04

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0352W H: $0.12

DTMXF NEWS

accessnewswire.com

2d ago

Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 Conglomerate

TORONTO, ON / ACCESS Newswire / April 9, 2026 / Datametrex AI Limited (the "Company" or "Datametrex") (TSXV:DM)(FSE:D4G)(OTC PINK:DTMXF) is pleased to announce the receipt of Purchase Orders (P.O.'s) with the total value of approximately $6,000,000 from an International Fortune 500 conglomerate for data centre expansion and optimization.

accessnewswire.com

3d ago

Datametrex Enters Strategic Agreement with Hilco Global to Advance Patent Monetization

TORONTO, ON / ACCESS Newswire / April 8, 2026 / Datametrex AI Limited (the "Company" or "Datametrex") (TSXV:DM)(FSE:D4G)(OTC PINK:DTMXF) is pleased to announce that its wholly owned subsidiary, Paymetrex Payment Solutions Inc. ("Paymetrex"), has entered into an agreement on March 23, 2026 with the IP Services Practice of Hilco Global, a global financial services and advisory firm, to support the monetization of Paymetrex's patent portfolio. Hilco Global offers a comprehensive suite of intellectual property (IP) advisory and related capabilities across its platform of companies, including valuation, structured sales processes, intellectual property auctions, direct investment, licensing strategies, and brand monetization initiatives.

accessnewswire.com

Mar 19

Datametrex Subsidiary PayMetrex Highlights Strategic Relevance of Patent Portfolio to Rapidly Expanding SoftPOS Market

TORONTO, ON / ACCESS Newswire / March 19, 2026 / Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV:DM)(FSE:D4G)(OTC PINK:DTMXF) today announced that its wholly owned subsidiary, Paymetrex Payment Solutions Inc. ("Paymetrex"), and AnywhereCommerce Inc., on March 17, 2026, entered into a royalty-bearing license relating to Paymetrex's patent portfolio. Paymetrex's portfolio includes multiple issued U.S. and Canadian patents covering secure transaction processing, payment authorization workflows, and integrated mobile-based acceptance architectures.

accessnewswire.com

Mar 10

Datametrex Integrates AI to Healthcare To Enhance Efficiencies

TORONTO, ONTARIO / ACCESS Newswire / March 10, 2026 / Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV:DM)(FSE: D4G)(OTC:DTMXF) is pleased to announce the integration of AI software within its EMR (Electronic Medical Records) system to support physicians at the point of care. These AI-assisted functionalities include automated clinical documentation, intelligent document classification, real-time charting support, and AI-generated patient care planning.

accessnewswire.com

Feb 23

Paymetrex Engages Pelent AI to Accelerate Patent Licensing Program

TORONTO, ON / ACCESS Newswire / February 23, 2026 / Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV:DM)(FSE:D4G)(OTC PINK:DTMXF) is pleased to announce that its wholly owned subsidiary, Paymetrex Payment Solutions Inc. ("Paymetrex"), has engaged Pelent Patent Analytics ("Pelent") to enhance and accelerate Paymetrex's patent licensing and monetization program. The engagement, effective February 13, 2026, integrates Pelent's AI into Paymetrex's licensing workflow, supporting the identification of high-probability licensing targets and strengthening the Company's ability to unlock value from its intellectual property portfolio.

accessnewswire.com

Feb 18

Datametrex Receives $1M Order from Fortune 500 Client

TORONTO, ON / ACCESS Newswire / February 18, 2026 / Datametrex AI Limited (the "Company" or "Datametrex") (TSXV:DM)(FSE:D4G)(OTC:DTMXF) is pleased to announce the receipt of a Purchase Order ("P.O.") from a large Fortune 500 company headquartered in South Korea, with offices across Asia and diversified business interests including consumer retail and other sectors.

Company Profile

Datametrex AI Limited, together with its subsidiaries, provides collecting, analyzing, and presenting structured and unstructured data using its patented machine learning and artificial intelligence in Canada and South Korea. The company operates through two segments, AI and Technology and Health Security. It offers health security services, such as COVID-19 related services, concierge medical services, and telemedicine services, as well as big data, artificial intelligence, and system integration services. The company also sells Covid-19 test kits. In addition, it provides NexaSecurity, a social-media discovery and monitoring platform; Nexalogy's Social Media Automated Reporting Technologies; and Datametrex EV solutions. Further, the company provides Medi-Call health app, a subscription service that connects patients with doctors, providing technology-driven e-health or m-health care services including prescriptions and in-person visits to a residential or work setting. Datametrex AI Limited is headquartered in Toronto, Canada.

Sector

Technology

Industry

Information Technology Services

Employees

IPO Date

2017-11-01

Beta

1.55

Websitewww.datametrex.com↗